- Home
- LPAA vs DMAC Comparison
LPAA vs DMAC Comparison
Compare LPAA & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPAA
- DMAC
- Stock Information
- Founded
- LPAA 2024
- DMAC 2000
- Country
- LPAA United States
- DMAC United States
- Employees
- LPAA N/A
- DMAC N/A
- Industry
- LPAA
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- LPAA
- DMAC Health Care
- Exchange
- LPAA Nasdaq
- DMAC Nasdaq
- Market Cap
- LPAA 290.4M
- DMAC 267.7M
- IPO Year
- LPAA 2024
- DMAC N/A
- Fundamental
- Price
- LPAA $10.20
- DMAC $5.13
- Analyst Decision
- LPAA
- DMAC Strong Buy
- Analyst Count
- LPAA 0
- DMAC 3
- Target Price
- LPAA N/A
- DMAC $8.00
- AVG Volume (30 Days)
- LPAA 46.5K
- DMAC 74.9K
- Earning Date
- LPAA 01-01-0001
- DMAC 03-17-2025
- Dividend Yield
- LPAA N/A
- DMAC N/A
- EPS Growth
- LPAA N/A
- DMAC N/A
- EPS
- LPAA N/A
- DMAC N/A
- Revenue
- LPAA N/A
- DMAC N/A
- Revenue This Year
- LPAA N/A
- DMAC N/A
- Revenue Next Year
- LPAA N/A
- DMAC N/A
- P/E Ratio
- LPAA N/A
- DMAC N/A
- Revenue Growth
- LPAA N/A
- DMAC N/A
- 52 Week Low
- LPAA $9.66
- DMAC $2.14
- 52 Week High
- LPAA $10.20
- DMAC $6.82
- Technical
- Relative Strength Index (RSI)
- LPAA N/A
- DMAC 37.74
- Support Level
- LPAA N/A
- DMAC $5.49
- Resistance Level
- LPAA N/A
- DMAC $6.11
- Average True Range (ATR)
- LPAA 0.00
- DMAC 0.34
- MACD
- LPAA 0.00
- DMAC -0.09
- Stochastic Oscillator
- LPAA 0.00
- DMAC 8.97
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.